SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-015037
Filing Date
2024-04-17
Accepted
2024-04-17 16:22:33
Documents
16
Period of Report
2024-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42735
2 ex10-1.htm EX-10.1 61866
3 ex99-1.htm EX-99.1 14332
4 ex99-1_001.jpg GRAPHIC 16343
  Complete submission text file 0001493152-24-015037.txt   336428

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ser-20240412.xsd EX-101.SCH 3042
6 XBRL LABEL FILE ser-20240412_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ser-20240412_pre.xml EX-101.PRE 22378
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3730
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 24851347
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)